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1. Introduction 
Several years ago a close structural similarity 
between human growth hormone (HGH) and human 
platen tal lactogen (HPL), also known as human 
chorionic somatomammotropin (HCS), was proposed 
on the basis of physiological and immunological data 
[ l-31 , and could be contirrned by several studies on 
the amino acid sequences of the two hormones [4, 51 
Recently we could show that despite this high degree 
of structural similarity a cross-reacting anti-human 
growth,hormone serum may be resolved into a mono- 
specific antibody population [6] . 
A very recent publication [ 71 indicates that the 
regions of homology seem to include more than 90% 
of all sequence positions. This finding prompts us to 
report our experiments on the isolation of a mono- 
specific antibody population from a cross-reacting 
anti-human placental lactogen serum. 
2. Materials and methods 
Antiserum to HPL used throughout this study was 
obtained from a single rabbit immunized with HPL, 
which was purchased from Nutritional Biochemicals 
Corp., Cleveland, Ohio, USA. Immunoglobulins were 
prepared from this antiserum by sodium sulphate 
precipitation. The immunoglobulins were dissolved in 
0.01 M phosphate buffer (pH 7.4), 0.145 M NaCl and 
0.02% NaNa to a volume corresponding to that of 
the serum and stored deep frozen at -2O”, 
NIII-GH-H1207A and HPL 196A were used for label- 
ling and as standard. Iodination of HGH and HPL was 
North-Holland Publishing Company - Amsterdam 
performed by a modification of a method reported 
previously [S] . The attachment of HGH to Sepharose 
was done as described recently for HPL [6 3. The 
solution of immunoglobulins was diluted 1: 10 and 
passed through a column packed with HGH-Sepharose. 
Elution was started with 0.01 M phosphate buffer 
(PH 7.4), 0.036 M NaCl and adsorbed antibodies were 
eluted with 3 M KSCN at neutral pH. The eluted 
fractions were dialyzed against buffered saline. The 
binding capacities of all fractions were determined by 
a modification of a radioimmunoassay system reported 
previously [9] using ‘251-HPL and 12’I-HGH as tracer. 
Cross-reaction was checked by plotting a dose- 
response curve. The data were obtained with a modi- 
fication of a solid-phase radioimmunoassay system 
recently described [ 101. 
3. Results and discussion 
An antiserum to HPL from a single rabbit showed 
a strong cross-reaction with HGH. Biphasic titration 
curves of this anti-HPL serum were obtained when its 
binding capacities were checked at serial dilutions 
against 12’I-HPL and 12’I-HGH in a radioimmunologi- 
cal system (fig. 1). We found a biphasic dose-response 
for this antiserum by radioimmunoassay. This biphasic 
curve of the antiserum before chromatography on HGH- 
Sepharose is characterized by an initial displacement 
of i2’I-HPL by HGH. Then a prolonged plateau is 
observed where increasing doses of HGH fail to dis- 
place the tracer (fig. 2). These observations suggested 
two populations of antibodies against HPL, one cross- 
reacting and the other showing no cross-reaction with 
HGH. 
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Fig. 1. Titration curves of the unpurified immunoglobulins of the anti-HPL serum. 
Separation of cross-reacting and monospecific anti- 
body populations was attempted by chromatography 
of the anti-HPL serum on HGH-Sepharose. The results 
(fig. 3) are reported in percentage binding of tracer of 
specific activity of 100 &i/pg. The binding capacity 
of the antiserum at 1 :lOO dilution before chromato- 
graphy on HGH-Sepharose was 6 1.1 percent against 
HPL and 59.8 percent against HGH, respectively, and 
these data are indicated on the ordinate in fig. 3. 
Cross-reacting antibody populations were adsorbed 
by HGH-Sepharose and retarded on the column. Al- 
most 100 percent of the specific anti-HPL population 
was recovered in fraction 1 as estimated from its 
binding capacity. The protein concentration in each 
fraction was determined by the absorbance at 280 nm 
(fig. 3)..90 Percent of the protein applied to the 
column was found in fraction 1. The remaining 10 
percent could be eluted in fraction 36 by 3 M KSCN. 
Fraction 1 was rechromatographed on HGH-Sepharose 
and no further adsorption was detected. Chromato- 
graphy of the antibody peak of fraction 36 resulted 
in complete adsorption on HGH-Sepharose. Anti-HPL 
serum was not adsorbed on uncoupled Sepharose. 
This rules out both incomplete binding due to overload 
and non-specific adsorption. 
Fig. 2. Dose-response curves of the unpurified immunoglobulins Fraction 1 was checked for cross-reaction in a 
of anti-HPL serum and of fraction 1. radioimmunoassay system and compared with the 
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Fig. 3. Chromatography of 1.0 ml immunoglobulin solution of the anti-HPL serum at a 1:lO dilution on 1 ml bed volume of HGH- 
Sepharose. Elution was started with phosphate buffer (see text) and 10 ml each of fraction 1 through 35 were collected. Elution 
of bound antibodies was started at fraction 36 with 5 ml each of a 3 M KSCN solution. Left ordinate: percentage binding of the 
immunoglobulin solution before chromatography. 
antiserum before chromatography on HGH-Sepharose 
(fig. 2). The unpurified anti-HPL exhibited 70 percent 
cross-reaction with HGH, but no cross-reaction was 
detectable in fraction 1. A strong displacement of 
“‘1-HPL by HGH and a biphasic dose-response with 
HGH was observed with the original antiserum in a 
solid-phase radioimmunoassay system. However, no 
displacement was noted for fraction 1 in the same 
system under otherwise identical conditions (fig. 2). 
We found a single dose-response curve with the original 
antiserum using 12’I-HGH as tracer and unlabelled 
HPL and HGH, respectively (as standard. No standard 
curve could be obtained with fraction 1 under condi- 
tions otherwise identical to those of the latter experi- 
ment (fig. 2). 
The experiments described here have permitted 
the rapid isolation of a monospecific antibody jpopula- 
tion from a cross-reacting anti-HPL serum. This is of 
interest since radioirnmunologic estimations of HPL 
at early stages of pregnancy, when o ly small amounts 
of HPL are present in pregnancy serum, are hampered 
by the strong cross-reaction of anti-HPL sera with 
HGH. The second implication of our work described 
here involves the recent report [7] on the amino acid 
sequences of HPL and HGH. This indicates that the 
regions of homology between the two hormones in- 
clude more than 90 percent of all sequence positions. 
This suggests that differences in immunological pro- 
perties between HPL and HGH may depend on com- 
paratively circumscribed sequence differences. Work 
is in progress to isolate that part of the HF’L molecule 
which elicits the monospecific antibody population. 
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